Is this your brand? Sign in to claim ownership.
Sign in to claim this brandExelint International, Co.
United States·US-MF-000037396
Last updated September 17, 2026
Information
- Country
- United States
- Address
- 2500, Santa Fe Ave., Redondo Beach, United States
- Website
- www.exelmedintl.com
- facebook.com/exelintinternational
- [email protected]
- Phone
- +1-310-649-0707
- PRRC Contact
- Vu Doan
- EUDAMED SRN
- US-MF-000037396
- FDA FEI Number
- 1035907
- DUNS Number
- —
Catalogue (312)
Page 2 of 7Related Companies
Authorised Representatives
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (3)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Dec 23, 2009 | Z-0638-2010 | — | terminated | Non-coring needles that, when inserted into an implanted port, were shown to core the silicone port's septum. Coring of port's septum may lead to: decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in pulmonary embolism, limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material; may lead to local tissue |
| Dec 23, 2009 | Z-0639-2010 | — | terminated | Coring of port's septum, which may lead to: Decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in Pulmonary Embolism, Limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material, may lead to local tissue necrosis, granulomas, failure to deliver therapy, need for additional surgery to replace implanted port |
| Dec 23, 2009 | Z-0640-2010 | — | terminated | Coring of port's septum, which may lead to: Decreased effectiveness of port, infection, necrosis, swelling, and embolization, which may result in Pulmonary Embolism, Limb ischemia, stroke, local extravasation of medication such as chemotherapy or other caustic material, may lead to local tissue necrosis, granulomas, failure to deliver therapy, need for additional surgery to replace implanted port |